Sodium Intake Linked to Atopic Dermatitis and Disease Severity

by drbyos

Sodium Intake Linked to Atopic Dermatitis and Disease Severity

Atopic dermatitis (AD), the most common form of eczema, affects millions of people worldwide. Characterized by inflammation, skin dryness, itch, and rash, its exact cause remains unknown. However, a recent study provides compelling evidence linking higher dietary sodium to increased risk and severity of AD.

Understanding the Study

A cross-sectional study by Chiang and colleagues, published in the Journal of the American Medical Association Dermatology, involved 215,832 participants aged 30 years and older from the UK Biobank. The study focused on 24-hour urine sodium excretion as a biomarker, adjusting for factors like body mass index, sex, age, and other urinary concentrations.

The study found that participants with a higher average sodium excretion—around 3.01 grams per day—had a significantly increased risk of developing AD. Specifically, a one-gram rise in sodium excretion correlated with an 11% higher chance of AD, a 16% higher risk of active AD, and an 11% higher likelihood of severe AD.

The Role of Sodium in AD

Research indicates that sodium stored in the skin can stimulate the immune system, leading to increased inflammation. This hyperactivation of the immune system is a hallmark of AD, suggesting that excess sodium may be a contributing factor to its development and severity.

Prevalence of Atopic Dermatitis

According to GlobalData epidemiologists, the number of people diagnosed with AD is projected to rise from 42 million in 2024 to about 42.5 million by 2033 across the 7MM (France, Germany, Italy, Japan, Spain, the UK, and the US). Approximately 85% of these cases are mild to moderate, while 15% are severe.

Implications for Treatment and Prevention

The findings of this study suggest a new, potentially accessible intervention for AD: reducing dietary sodium intake. This simple lifestyle change could be a cost-effective method to improve patient outcomes and enhance quality of life.

While additional research is necessary to validate these findings and explore the underlying mechanisms, the study represents a significant step forward in understanding and managing AD.

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Your download email will arrive shortly

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData


Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Join the conversation. Share your thoughts on this study and its implications for atopic dermatitis management. Leave a comment below, and don’t forget to subscribe to our newsletter for the latest updates.

Related Posts

Leave a Comment